Literature DB >> 31017450

Pseudomyogenic Hemangioendothelioma (Epithelioid Sarcoma-Like Hemangioendothelioma).

Gustavo A Caballero1, Pablo D Roitman1.   

Abstract

Pseudomyogenic hemangioendothelioma (PMH) is a rare vascular tumor that presents more frequently in young adults and has a male predominance. It is usually located in the superficial or deep soft tissues of the extremities, but concurrent bone involvement can be present. In approximately two-thirds of patients this disease is multifocal, often involving multiple tissue planes. It is a relapsing lesion with low metastatic potential. Given its clinical and morphologic characteristics (multifocality, epithelioid morphology, absence of clearly evident vascular differentiation on hematoxylin-eosin slides), PMH can be easily misinterpreted as other lesions, often with radically different treatment and prognosis. For this reason, we think it is important to recognize this entity, which has some unique features. Here, we will briefly describe the clinical and pathologic features of PMH, detailing its more relevant differential diagnoses.

Entities:  

Year:  2019        PMID: 31017450     DOI: 10.5858/arpa.2018-0395-RS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

Review 1.  Malignant Superficial Mesenchymal Tumors in Children.

Authors:  Philippe Drabent; Sylvie Fraitag
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

Review 2.  Pseudomyogenic hemangioendothelioma with bone and soft tissue involvement with favorable response to pamidronate: a case report and systematic review of the literature.

Authors:  María Lorena Brance; Nicolás M Cóccaro; Pablo Roitman; Alejandro Castiglioni; Florencia Agostinis; Mariel Spense; Bárbara Scheitlin; Nicholas Rene; Lucas R Brun
Journal:  Arch Osteoporos       Date:  2022-02-01       Impact factor: 2.617

3.  "Pseudotumors" in Dermatology.

Authors:  Vishal Gaurav; Chander Grover
Journal:  Indian Dermatol Online J       Date:  2022-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.